| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2012.05.003 |
| P698 | PubMed publication ID | 22658966 |
| P2093 | author name string | Malabi M Venkatesan | |
| Ryan T Ranallo | |||
| Suramya Fonseka | |||
| Robert W Kaminski | |||
| Sejal Thakkar | |||
| Lisa A Bedford | |||
| Tara L Boren | |||
| P2860 | cites work | Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli | Q24804947 |
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology | Q28767862 | ||
| Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant | Q29615039 | ||
| A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR | Q29615324 | ||
| Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate. | Q30369367 | ||
| Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants | Q33557800 | ||
| Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli | Q33597022 | ||
| Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo | Q33617990 | ||
| Scarless and sequential gene modification in Pseudomonas using PCR product flanked by short homology regions | Q33648542 | ||
| Surprising dependence on postsegregational killing of host cells for maintenance of the large virulence plasmid of Shigella flexneri | Q33726839 | ||
| The stability region of the large virulence plasmid of Shigella flexneri encodes an efficient postsegregational killing system | Q33789850 | ||
| Rapid and highly efficient method for scarless mutagenesis within the Salmonella enterica chromosome | Q33802758 | ||
| Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin | Q33859430 | ||
| Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602 | Q33876803 | ||
| Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans | Q34003433 | ||
| Parameters underlying successful protection with live attenuated mutants in experimental shigellosis | Q34006071 | ||
| Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults | Q34120926 | ||
| Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers | Q34194587 | ||
| Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro | Q34224319 | ||
| Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. | Q35772614 | ||
| virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence | Q36173163 | ||
| Live-attenuated Shigella vaccines | Q36689023 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector | Q36989608 | ||
| Inactivated and subunit vaccines to prevent shigellosis | Q37640115 | ||
| Shigella are versatile mucosal pathogens that circumvent the host innate immune system. | Q37901683 | ||
| Differential regulation by magnesium of the two MsbB paralogs of Shigella flexneri. | Q38608685 | ||
| Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
| Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions | Q39461241 | ||
| Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine | Q39517102 | ||
| Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells | Q39610195 | ||
| Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain. | Q40460000 | ||
| Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. | Q40469794 | ||
| Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children | Q40552513 | ||
| Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers | Q40723111 | ||
| High vaccine efficacy against shigellosis of recombinant noninvasive Shigella mutant that expresses Yersinia invasin | Q41452257 | ||
| Developing live Shigella vaccines using lambda Red recombineering | Q41452880 | ||
| Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. | Q43432983 | ||
| Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium | Q43982547 | ||
| A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages | Q44118567 | ||
| Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis | Q44965347 | ||
| Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea | Q47361536 | ||
| New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. | Q53579124 | ||
| Prevalence of Shigella Enterotoxin 1 among Shigella Clinical Isolates of Diverse Serotypes | Q54601009 | ||
| PCR-mediated gene replacement in Escherichia coli | Q73682242 | ||
| Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells | Q73948765 | ||
| Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine | Q84592118 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Shigella flexneri | Q1644417 |
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 5159-5171 | |
| P577 | publication date | 2012-05-30 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates | |
| P478 | volume | 30 |
| Q37668395 | An update on vaccines against Shigella |
| Q37335984 | Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine. |
| Q35896237 | Combination vaccines against diarrheal diseases |
| Q42120657 | In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation |
| Q35854136 | Isolation and Comparative Genomic Analysis of T1-Like Shigella Bacteriophage pSf-2. |
| Q87281013 | Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes |
| Q37105553 | Progress and pitfalls in Shigella vaccine research |
| Q36981626 | Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malaria |
| Q35887055 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. |
Search more.